Why vaccination is only a part-solution
dc.contributor.author | D'Souza, Errol | |
dc.date.accessioned | 2020-12-12T14:10:43Z | |
dc.date.available | 2020-12-12T14:10:43Z | |
dc.date.issued | 2020-12-10 | |
dc.identifier.uri | http://hdl.handle.net/11718/23344 | |
dc.description | BUSINESS LINE 09/12/2020 P.05 PRESSREADER | en_US |
dc.publisher | Business Line | en_US |
dc.subject | Vaccination | en_US |
dc.subject | BioNTech-Pfizer vaccine | en_US |
dc.subject | COVID-19 | en_US |
dc.title | Why vaccination is only a part-solution | en_US |
dc.type | Newspaper | en_US |
Files in this item
This item appears in the following Collection(s)
-
IIMA In Media [7032]
News on Indian Institute of Management